A D2 antagonist enhances the rewarding and priming effects of a gambling episode in pathological gamblers (Q38400678)

2 September 2017

A D2 antagonist enhances the rewarding and priming effects of a gambling episode in pathological gamblers (English)

1 reference

2 September 2017

Martin Zack

1

1 reference

2 September 2017

Constantine X Poulos

series ordinal

2

1 reference

2 September 2017

language of work or name

English

0 references

publication date

3 January 2007

1 reference

2 September 2017

Neuropsychopharmacology

1 reference

2 September 2017

32

1 reference

2 September 2017

8

1 reference

2 September 2017

1678-1686

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.npp.1301295

2 September 2017

0 references

cites work

Remoxipride, a specific D2 dopamine antagonist: an examination of its self-administration liability and its effects on d-amphetamine self-administration

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301295

Do novel antipsychotics have similar pharmacological characteristics? A review of the evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301295

D1-like and D2 dopamine receptor antagonists administered into the shell subregion of the rat nucleus accumbens decrease cocaine, but not food, reinforcement

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301295

Characteristics of problem gambling in a Canadian context: a preliminary study using a DSM-IV-based questionnaire.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301295

Subjective responses to d-amphetamine alone and after pimozide pretreatment in normal, healthy volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301295

High dose pimozide does not block amphetamine-induced euphoria in normal volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301295

Dopamine ligands and the stimulus effects of amphetamine: animal models versus human laboratory data

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301295

Evidence for involvement of both D1 and D2 receptors in maintaining cocaine self-administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301295

Individual differences in extraversion and dopamine genetics predict neural reward responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301295

The D2 receptor is critical in mediating opiate motivation only in opiate-dependent and withdrawn mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301295

Haloperidol reduces stimulant and reinforcing effects of ethanol in social drinkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301295

A comparison of the effects of risperidone, raclopride, and ritanserin on intravenous self-administration of d-amphetamine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301295

Correlation between dopamine D(2) receptors in the ventral striatum and central processing of alcohol cues and craving

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301295

Neuroendocrine response to casino gambling in problem gamblers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301295

Severity of gambling is associated with physical and emotional health in urban primary care patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301295

PET imaging of dopamine D2 receptors in monkey models of cocaine abuse: genetic predisposition versus environmental modulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301295

Addiction and its reward process through polymorphisms of the D2 dopamine receptor gene: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301295

Time course of D2-dopamine receptor occupancy examined by PET after single oral doses of haloperidol

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301295

Pathological gambling is linked to reduced activation of the mesolimbic reward system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301295

Binding of antipsychotic drugs to human brain receptors focus on newer generation compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301295

Effect of genes, environment, and lifetime co-occurring disorders on health-related quality of life in problem and pathological gamblers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301295

Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301295

Receptor subtypes in opioid and stimulant reward

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301295

Effects of intravenous cocaine are partially attenuated by haloperidol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301295

Low level of brain dopamine D2 receptors in methamphetamine abusers: association with metabolism in the orbitofrontal cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301295

The addicted human brain viewed in the light of imaging studies: brain circuits and treatment strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301295

Effects of chronic cocaine abuse on postsynaptic dopamine receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301295

Association of methylphenidate-induced craving with changes in right striato-orbitofrontal metabolism in cocaine abusers: implications in addiction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301295

Decreases in dopamine receptors but not in dopamine transporters in alcoholics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301295

Cardiovascular effects of methylphenidate in humans are associated with increases of dopamine in brain and of epinephrine in plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301295

Brain DA D2 receptors predict reinforcing effects of stimulants in humans: replication study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301295

Cocaine cues and dopamine in dorsal striatum: mechanism of craving in cocaine addiction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301295

The effects of acute haloperidol or risperidone on subjective responses to methamphetamine in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301295

Brain dopamine and obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301295

Unraveling dopamine D3 receptor function in response to psychostimulants using a genetic approach.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301295

Amphetamine Primes Motivation to Gamble and Gambling-Related Semantic Networks in Problem Gamblers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301295

Screening depressed patients in family practice. A rapid technic

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301295

7 January 2021

Dopamine D2 receptor gene variants: association and linkage studies in impulsive-addictive-compulsive behaviour

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301295

7 January 2021

The D2 dopamine receptor gene as a determinant of reward deficiency syndrome.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301295

7 January 2021

Role of dopamine D2-like receptors in cocaine self-administration: studies with D2 receptor mutant mice and novel D2 receptor antagonists

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301295

7 January 2021

Addiction Research Center Inventory (ARCI): development of a general drug estimation scale

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301295

7 January 2021

A shortened version of the Profile of Mood States

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301295

7 January 2021

Adjusting for differential base rates: Lord's paradox again

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301295

7 January 2021

Dopamine D2 receptor availability in opiate-dependent subjects before and after naloxone-precipitated withdrawal

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301295

7 January 2021

Identifiers

DOI

10.1038/SJ.NPP.1301295

1 reference

Dimensions Publication ID

2 September 2017

0 references

1 reference